Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Cited by (1,000)

Items 801–900 of 1,000

1. Canabidiol e suas indicações em psiquiatría
   Juan Fernando Muñoz Ramírez · 2021 · Revista Digital Palabra (Universidad Pontificia Bolivariana)
2. Plants come to mind: phytocannabinoids, endocannabinoids and the control of seizures
   Jordan S. Farrell, Iván Soltész · 2018 · Addiction
3. Letter to the Editor: The Receptor(s) via Which Cannabidiol Affects Muscle Signaling: In Need for More Insights
   Sebastiaan Dalle, Moniek Schouten, Katrien Koppo · 2022 · Cannabis and Cannabinoid Research
4. Comparison between Cannabidiol and Fluoxetine effects on chronic neuropathic pain and depression comorbid in rats
   Débora Thais Pereira Brito, Ana Carolina Medeiros, Christie Ramos Andrade Leite‐Panissi, Evelin Capellari Cárnio, Hélio Rubens Machado, Norberto Cysne Coimbra, Renato Leonardo de Freitas, Priscila Sanjuan de Medeiros · 2025 · Neuroscience and Behavioral Physiology
5. The Effects of THC and Nicotine on Attention: A Narrative Review
   Kennedy Oleszak, Lily Freeman-Striegel, Nicole M. Roeder, Patrick Mohr, Samantha L. Penman, Lorraine Collins, Danielle M. Smith, Panayotis K. Thanos · 2025 · Current topics in behavioral neurosciences
6. Developing a functional non-animal CNS stress model utilizing long-term potentiation with human iPSC-cortical neurons to evaluate therapeutics
   Kaveena Autar, Xiufang Guo, Haley Powell, Aakash Patel, Mridu Malik, Marcella Grillo, Nesar Akanda, Narasimhan Sriram Narasimhan, Will Bogen, Christopher J. Long et al. · 2025 · Biomedicine & Pharmacotherapy
7. Cannabidiol’s Antioxidant Properties in Skin Care Products and Legislative Regulations
   Maria Fafaliou, Αpostolos Papadopoulos, Panagoula Pavlou, Athanasia Varvaresou · 2025 · Plants
8. A Scoping Systematic Review of Cannabis Use in Endometriosis
   Kindha McLaren, Simon Erridge, Mikael Hans Sodergren · 2025 · Australian and New Zealand Journal of Obstetrics and Gynaecology
9. Cannabinoid Signaling and Autophagy in Oral Disease: Molecular Mechanisms and Therapeutic Implications
   Undral Munkhsaikhan, Md. Ataur Rahman, Alivia M. Shasteen, Karima Ait‐Aissa, Amal M. Sahyoun, Rajat Das Gupta, Modar Kassan, Ehsanul Hoque Apu, Ammaar H. Abidi · 2026 · International Journal of Molecular Sciences
10. Repeated administration of cannabidiol decreases splenic lymphocyte subset numbers in rats
    T Turkki, Maciej M. Jankowski, Wojciech Glac, Piotr Badtke, Viviane M. Saito, Artur Hugo Swiergiel, Bogna Marta Ignatowska-Jankowska · 2026 · International Journal of Immunopathology and Pharmacology
11. Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies
    Silvia Afonso, Joana Gonçalves, Ana Teresa Brinca, Luana M. Rosendo, Tiago Rosado, Ana Paula Duarte, Eugénia Gallardo · 2026 · Diseases
12. Cannabichromene attenuates fracture pain but impairs bone repair in a murine tibial fracture model
    Deepak Kumar Khajuria, Hwabok Wee, Zachary Koroneos, Mohamed A. Tantawy, Gregory S. Lewis, Wesley M. Raup‐Konsavage, Kent E. Vrana, Fadia Kamal, Reyad A. Elbarbary · 2026 · Bone
13. Functional selectivity of cannabinoids at CB1 receptors: Comprehensive analysis of G proteins, β-arrestin and cAMP signalling dynamics in HEK293T cells
    Noor AlAli, Benjamin Joel Wheaton, Stig O. P. Jacobsson · 2026 · European Journal of Pharmacology
14. CARE – A Retrospective, Dual-Cohort, 24-Week Real-World Study from the German Pain e-Registry on the Effectiveness and Safety of CBD-Dominant Oral Cannabis Extracts versus THC/Dronabinol in Older Patients with Chronic Pain
    Michael A. Ueberall, Philipp C. G. Müller-Schwefe, Michael A. Küster, Gerhard H. H. Müller-Schwefe · 2026 · Journal of Pain Research
15. Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1
    Pankaj Pandey, Ayat Zagzoog, Theodor Zaharia, Shamba Chatterjee, Ikhlas Ahmed Khan, Jason J. Paris, Robert B. Laprairie, Amar Gopal Chittiboyina · 2026 · Communications Chemistry
16. Improved drug delivery across the blood-brain barrier through post-insertion functionalization of lipid nanocapsules with cannabidiol using click chemistry
    Alexandre Pérez-López, Juan Aparicio-Blanco, Cristina Martín‐Sabroso, Cláudia Martins, Laura Gómez-Lázaro, Víctor Sebastián, Juan Francisco González-Matilla, Bruno Filipe Carmelino Cardoso Sarmento, Ana Isabel Torres-Suárez · 2026 · Colloids and Surfaces B Biointerfaces
17. Cannabinoids in the Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review of Randomized Controlled Trials
    Aritra Datta, Simon Erridge, Aditya Mukherjee, Ishita Acharya, Dhruv Vasooja, Uma Anand, Praveen Anand, Mikael H Sodergren · 2026 · Journal of Pain & Palliative Care Pharmacotherapy
18. Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration
    Daniel K. Fowler, Tylor M. Savage, Duncan Ian Mackie · 2026 · Journal of Cannabis Research
19. Mind the Gap: Unraveling the Pharmacokinetic Variability of Δ9‐Tetrahydrocannabinol (THC)
    Shi Lu, Xin Liu, Linda Truong, Zheng Liu, Fei Guo, Jennifer H. Martin, Xiao Zhu · 2026 · The Journal of Clinical Pharmacology
20. Opioids and Cannabinoids in Neurology Practice
    Friedhelm Sandbrink, Nathaniel M. Schuster · 2024 · CONTINUUM Lifelong Learning in Neurology
21. Cannabidiol oil delays pancreatic islet dysfunction in Wistar rats under hypercaloric diet
    Edgardo Cortes-Justo, Rocı́o Ortiz-Butrón, Alonso Vilches‐Flores · 2025 · Biomedicine & Pharmacotherapy
22. Neurodevelopmental outcomes following prenatal cannabidiol exposure in male and female Sprague Dawley rat offspring
    Sarah L. Baccetto, Tallan Black, Ilne L. Barnard, Leah M Macfarlane, Genre B Sanfuego, Robert B. Laprairie, John G. Howland · 2025 · Neuroscience
23. Successful Treatment of Superior Oblique Myokymia With Cannabidiol Oil
    Jingyi Ma, Stéphanie Labbé, Jonathan Andrew Micieli · 2020 · Journal of Neuro-Ophthalmology
24. L’usage du cannabidiol dans le sport : une bonne idée ?
    François-Xavier Gamelin, Serge Berthoin, Grégory Cuvelier, A. Mendes, Agathe Anthierens, Elsa Heyman · 2021 · Science & Sports
25. Phytocannabinoids: Cannabidiol (CBD)
    Priodarshi Roychoudhury, Ning Nan Wang, Samer Narouze · 2021 · Springer eBooks
26. Cannabis bei Krebs – für welchen Einsatz haben wir Evidenz?
    Bijan Zomorodbakhsch, Jutta Hübner · 2022 · Die Onkologie
27. Nutraceutical potential of industrial hemp
    Viviana di Giacomo, Claudio Ferrante, Luigi Menghini, Giustino Orlando · 2022 · Elsevier eBooks
28. Le potentiel thérapeutique du cannabidiol chez les sujets présentant un trouble du spectre psychotique : une revue systématique de la littérature sur les essais contrôlés randomisés
    Florian Martin, Caroline Dubertret, Yann Le Strat, Jasmina Mallet · 2023 · Annales Médico-psychologiques revue psychiatrique
29. Alterations of THC and CBD ratios and impact on cognition
    Erica Zamberletti · 2023 · Elsevier eBooks
30. A type II cannabis extract and a 1:1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space
    Besma Benredjem, Graciela Piñeyro · 2023 · Frontiers in Pharmacology
31. Physiological profiling of cannabidiol reveals profound inhibition of sensory neurons
    Gracesenia Chahyadinata, Joo Hyun Nam, Ashley Battenberg, Brian J. Wainger · 2024 · Pain
32. Repeated Administration of a Full-Spectrum Cannabidiol Product, Not a Cannabidiol Isolate, Reverses the Lipopolysaccharide-Induced Depressive-Like Behavior and Hypolocomotion in a Rat Model of Low-Grade Subchronic Inflammation
    Linério Ribeiro de Novais Júnior, Tiago Vicente da Silva, Larissa Mendes da Silva, Flavia Metzker de Andrade, Alisson Reuel da Silva, Vicente Meneguzzo, Suelen de Souza Ramos, Cyntia Michielin Lopes, Artur Bernardo Saturnino, Antonio Inserra et al. · 2024 · Cannabis and Cannabinoid Research
33. The impact of cannabis use on local anesthetic dosing during hair restoration surgery: a case report, proposed mechanisms, and clinical recommendations
    Aditya Kumar Gupta, Mesbah Talukder, Sharon A. Keene · 2025 · Journal of Dermatological Treatment
34. Cannabidiol (CBD) and Colorectal Tumorigenesis: Potential Dual Modulatory Roles via the Serotonergic Pathway
    Zhenhua Liu · 2025 · Current Oncology
35. Targeting the endocannabinoid system to suppress mTORC1 hyperactivation in TSC-associated kidney disease
    Eden Abergel, Hadass Pri‐Chen, Shulamit B. Wallach‐Dayan, Liad Hinden, Joseph Tam, Oded Volovelsky, Morris Nechama · 2025 · American Journal of Physiology-Renal Physiology
36. Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease
    Chong-Lei Fu, Xuehui Li, Xiaoxing Liu, Yongbo Zheng, Xiangxian Ma, Bo Zhang, Si Xuan Chen, Lingming Hu, Sizhen Su, Xiaokun Wang et al. · 2025 · Translational Neurodegeneration
37. Cannabidiol and Parkinson's disease: Investigating receptor interactions and their therapeutic implications
    Eric A Okrah, Claire Yvonne Allan, Monika S. Doblin, Sarah Jane Annesley · 2025 · Pharmacology & Therapeutics
38. Cannabidiol and Cannabis Use Disorder
    María S. García‐Gutiérrez, Francisco Navarrete, Adrián Viudez‐Martínez, Ani Gasparyan, Esther Caparrós, Jorge Manzanares · 2018 · Springer eBooks
39. Evaluating the Abuse Potential of Lenabasum, a Selective Cannabinoid Receptor 2 Agonist
    Rachel R. Luba, Gabriela Madera, Rebecca Schusterman, Andrew F. Kolodziej, Ian Hodgson, Sandra D. Comer · 2024 · Journal of Pharmacology and Experimental Therapeutics
40. Pharmacological characterisation of the CB1 receptor antagonist activity of cannabidiol in the rat vas deferens bioassay
    Amna C. Mazeh, James A. Angus, Christine E. Wright · 2021 · European Journal of Pharmacology
41. A study of GPR3, GPR6, of GPR12 as novel molecular targets for cannabidiol.
    Alyssa S. Laun · 2018
42. Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane
    Mohammad‐Reza Ghovanloo, Jonathon Carl Arnold, Peter C. Ruben · 2023 · Frontiers in Physiology
43. Unifying Phytochemistry, Analytics, and Target Prediction to Advance Dendropanax morbifera Bioactive Discovery
    SuHyun Kim, Damhee Lee, Kyujeong Won, JinSeop Lee, Wooseop Lee, Woohyeon Roh, Young Jun Kim · 2026 · Life
44. Sublingual Administration for Pain Control: Pharmacology, Clinical Applications and Future Directions
    Sarang S. Koushik, Karina Gritsenko, Dhanesh D. Binda, Isaac S. Daybell, Nathan S. Hill, Jagun Raghavan, Emmanuella Borukh, Bradford B. Smith, Molly B. Kraus, Naum Shaparin · 2026 · CNS Drugs
45. Novel pharmacotherapies for opioid use disorder and opioid withdrawal
    Mary R. Shen, Kwadwo E. Owusu-Boaitey, Z. Murphy, Alex Rains, Philip R. Wang, Dennis W. Zhou, Joji Suzuki · 2026 · Frontiers in Psychiatry
46. Effects of Cannabidiol in Adolescent and Young Adult Depressive and Anxiety Disorders: A Systematic Review of Clinical and Preclinical Research
    Rebecca K. Denson, Julia M. Brooks, Graziano Pinna, Natania A. Crane · 2023 · Adolescent Psychiatry
47. The Interplay of Exogenous Cannabinoid Use on Anandamide and 2-Arachidonoylglycerol in Anxiety: Results from a Quasi-Experimental Ad Libitum Study
    Renée Martin‐Willett, Carillon J. Skrzynski, Ethan M. Taylor, Cristina Sempio, Jost Klawitter, L. Cinnamon Bidwell · 2024 · Pharmaceuticals
48. ESCAPE Study: Cannabidiol Use in Patients Treated for Substance Use Disorders, Prevalence of Use, and Characteristics of Users
    Mélanie Duval, Marion Istvan, Morgane Rousselet, Edouard‐Jules Laforgue, Marie Grall‐Bronnec, Claire Mauriat, Caroline Victorri‐Vigneau · 2024 · European Addiction Research
49. Empfehlungen der DGRh-Kommission für Komplementäre Heilverfahren und Ernährung zur Anwendung von ausgewählten Phytotherapeutika und pflanzlichen Präparaten in der Rheumatologie
    Gernot Keyßer, Olga Seifert, Inna Frohne, Andreas Michalsen, Alexander Pfeil, Monika A Reuss-Borst, Oliver Sander · 2025 · Zeitschrift für Rheumatologie
50. Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol, Prevented by Cannabidiol Co-Treatment
    Ya‐Lin Sun, Meenalochani Sivasubramanian, Marija Milenkovic, Andrew B. Gumbert, Jack Bergman, Preston Ge, Myriam Heiman, Marie-Eve Di Raddo, Sarah Louise Withey, Bertha Kalifon Madras et al. · 2025 · Biological Psychiatry Global Open Science
51. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models
    Margaret F. Bedillion, Catherine F. Moore, Elise M. Weerts, Caroline A. Arout, Hannah M. Harris, Margaret Haney · 2025 · Current topics in behavioral neurosciences
52. Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study
    Hind Ibork, Zakaria Ait lhaj, Farhan Siddique, Sara El Idrissi, Farid Khallouki, Rafik El-Mernissi, Lhoussain Hajji, Hanane Khalki, Mohammed Bourhia, Ahmad Mohammad Salamatullah et al. · 2025 · Open Life Sciences
53. Evidence for Cannabidiol as a Medication for the Treatment of Neurological, Psychiatric, Behavioral and Substance Use Disorders in Adolescents
    Jennifer A. Ross, William Riccardelli, James Robitaille, Sharon Levy · 2025 · Adolescents
54. Cannabidiol releases CB1R from A2AR repression in ischemic stroke
    Iu Raïch, Jaume Lillo, Joan Biel Rebassa, Rafael Rivas‐Santisteban, Montserrat Santandreu, Irene Reyes‐Resina, José Antonio Martínez-Orgado, Gemma Navarro · 2025 · Neurobiology of Disease
55. Measuring the Effects of Cannabis on Anxiety and Depression Among Cancer Patients
    Apoorva C. Reddy, John M. Hampton, Susan J. Park, Faith Dickerson, Janvi Shah, Betty A Chewning, Natalie S. Schmitz, Amy Trentham‐Dietz · 2025 · Cancer Medicine
56. Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3)
    Kevin Martinez, María Belén Palma, Fernando J. Sepúlveda, Damián E. Moavro, Edgardo Delfino Carosella, Marcela Nilda García, F.L. Riccillo · 2025 · Scientific Reports
57. Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study
    Elizabeth Berry‐Kravis, Randi Jenssen Hagerman, Jonathan Cohen, Dejan B. Budimirovic, Caroline B. Buchanan, Natalie Silove, Nancy Tich, Anthony Thibodeau, Thomas W Dobbins, Terri B. Sebree et al. · 2025 · Journal of Neurodevelopmental Disorders
58. Investigating the effectiveness and adverse events of medicinal cannabis for patients with muscle spasticity or spasms
    Xenia L. Nastatos, Elise A. Schubert, Nial Wheate · 2025 · Journal of Pharmacology and Experimental Therapeutics
59. Cannabidiol reduces LPS-induced inflammatory response in the human placenta by reducing NF-κB translocation
    Ramon Portillo, Tetiana Synova, Mohammad Ghaddar, Mia Salma Alsouki, Fiona Kumnova, Miloslav Macháček, Rona Karahoda, Cilia Abad, František Štaud · 2025 · Journal of Cannabis Research
60. NEUROPSYCHIATRIC AND PSYCHOGENETIC ASPECTS OF POST-TRAUMATIC STRESS DISORDERS ASSOCIATED WITH THE CHORNOBYL DISASTER AND THE RUSSIAN-UKRAINIAN WAR: FOCUS ON THE ENDOCANABINOID SYSTEM
    K. Kuts, Heorhii KREINIS, I.V. Perchuk, Katerina Y. Antypchuk, Zlata VASYLENKO, V. I. Kravchenko, N. V. Drozdova · 2025 · Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology
61. Inhibitory effects of (synthetic) cannabinoids and (designer) benzodiazepines on spontaneously active neuronal networks of primary rat cortical cultures in vitro
    J. Pepijn Wopken, Jack R. Thornton, Regina G.D.M. van Kleef, Remco H.S. Westerink · 2025 · NeuroToxicology
62. Cannabidiol Regulates CD47 Expression and Apoptosis in Jurkat Leukemic Cells Dependent upon VDAC-1 Oligomerization
    Lixing Wang, Suzanne Samarani, Evgenia Fadzeyeva, MariaLuisa Vigano, Alia As’sadiq, Branka Vulesevic, Ali Ahmad, Cecilia Theresa Costiniuk · 2026 · Pharmaceuticals
63. Effect of cannabidiol on traumatic brain injury–related neuronal damage pathways
    Ayşe Başak Engin, Atilla Engin · 2026 · Current Opinion in Toxicology
64. Exploring Linalool‐Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition
    Ilaria Piccialli, Giovanni Roviello, Giorgia Magliocca, Emilia Esposito, Anna Pannaccione · 2026 · Phytotherapy Research
65. Cannabinoids in Combination with Conventional Breast Cancer Therapies: Mechanistic Insights and the Gap to Clinical Translation
    Anja Bizjak, Uroš Potočnik, Helena Čelešnik · 2026 · Cancers
66. Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats
    Riyadh S. Almalki · 2026 · Drug Design Development and Therapy
67. Refining Cannabinoid Ratios for Geriatric Pain: Methodological and Clinical Reflections on the CARE Study [Letter]
    Di Qiang, Chen Zheng, Yingying Y. Xu · 2026 · Journal of Pain Research
68. CBD Promotes Structural and Functional Epithelial Restoration and Alleviates Inflammation in a Mouse Model of Interstitial Cystitis
    Dominika Peskar, Mojca Kerec Kos, Špela Tavčar, Katja Lakota, Nika Kojc, Peter Veranič, Andreja Erman · 2026 · Pharmaceutics
69. Pharmacological Insights into Cannabidiol for Wound Healing and Bone Regeneration
    Letícia Pereira Lima Durão, Daniela Moreira Cunha, Marta Maria Alves Pereira, Érica Dorigatti de Ávila, Patricia Milagros Maquera-Huacho · 2026 · ACS Omega
70. Phytocannabinoids in Central Nervous System Disorders and Frameworks for Cellular Stress Adaptation: A Comprehensive Review
    Hyewon Lee, Han–Jung Chae · 2026 · Innovations in Acupuncture and Medicine
71. Recent cannabis exposure and acute nicotine effects: insights from randomized, double-blind, placebo-controlled intravenous nicotine studies
    Gabriel P. A. Costa, Robert Ross MacLean, Mehmet Sofuoglu, João Paulo De Aquino · 2026 · The International Journal of Neuropsychopharmacology
72. UK Medical Cannabis Registry: an updated analysis of clinical outcomes of medicinal cannabis therapy for hypermobility-associated chronic pain
    Mariam Alemi, Simon Erridge, Evonne Clarke, Katy McLachlan, Ross Coomber, Shelley Barnes, Alia Darweish Medniuk, Rahul Guru, Wendy Holden, Mohammed Sajad et al. · 2026 · Clinical Rheumatology
73. Chapter 13. Mechanisms, Efficacy, and Safety of Cannabinoids for Treating Chronic Pain
    Mark K. Greenwald · 2024 · American Psychiatric Association Publishing eBooks
74. Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges
    Angelika Talar-Śpionek, Edyta Juszczuk‐Kubiak, Marek Łukasz Roszko · 2026 · Molecules
75. Does co-administration of cannabidiol (CBD) influence the plasma availability of delta-9-tetrahydrocannabinol (THC) and its active metabolite in humans? A systematic review and meta-analysis
    Lucy A. Chester, Heidar Sharafi, Amani Mahroug, Daniela Ziegler, François-Olivier Hébert, Didier Jutras‐Aswad · 2026 · Neuroscience & Biobehavioral Reviews
76. Cannabis Co-use and endocannabinoid system modulation in tobacco use disorder
    Gabriel P. A. Costa, Oscar Gómez, Lucas Ribeiro Rocha, Mayte A Cerezo-Matias, Melissa Christine Funaro, DVM Deniz Bagdas, Mehmet Sofuoglu, João Paulo De Aquino · 2026 · Neuroscience & Biobehavioral Reviews
77. The Ecology of Wild Cannabis sativa
    Ernest Small · 2016 · CRC Press eBooks
78. Cannabis Chemistry: Cannabinoids in Cannabis, Humans, and Other Species
    Ernest Small · 2016 · CRC Press eBooks
79. Characterizing chronic non-suicidal self-injury and other forms of repetitive and escalating suicide behaviour as endocannabinoid-mediated pain and reward disorders
    Hye Ji J. Kim, David A. Petrishen, Robert B. Laprairie, Evyn M. Peters · 2022 · Personalized Medicine in Psychiatry
80. Cannabidiol and Indole-3-carbinol Reduce Intracellular Lipid Droplet Accumulation in HepaRG, A Human Liver Cell Line, as well as in Human Adipocytes
    Sanjanaa Senthilkumar, Megan E. Solan, María Teresa Fernández-Luna, Ramón Lavado · 2023 · The Natural Products Journal
81. Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology
    Olivier Dionne, Armita Abolghasemi, François Corbin, Artuela Çaku · 2024 · Psychiatry Research
82. Therapeutic application of cannabis and its derivatives
    Moitreyee Chattopadhyay, Ananya Chanda, Arghya Bhattacharya · 2024 · Elsevier eBooks
83. The impact of cannabis on endurance and performance of athletes - risks and benefits - a literature review
    Paweł Nojek, Gustaw Błaszczyński, Agnieszka Nowotarska, Wiktoria Pawlik, Mariusz Zimonczyk, Monika Zawół · 2024 · Journal of Education Health and Sport
84. Cognitive Stimulants: from Caffeine to Cannabinoids - Current and Future Perspectives
    2025 · Frontiers research topics
85. Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe
    Miroslav Kosar, Themiya Perera, Rudolf L. Z. Ganzoni, Roman C. Sarott, Leire Borrega‐Roman, Rosa Maria Vitale, Alessia Ligresti, Arne Christian Rufer, Wolfgang Guba, Uwe Grether et al. · 2025 · Angewandte Chemie
86. Recreational Drugs Repurposed for Medicinal Use – Cannabis
    Mike Armour, Justin Sinclair, Hannah Adler · 2025 · Cambridge University Press eBooks
87. Sustainable synthesis of cannabinoids via metal-free aromatic deformylation
    Gil Dinnar, Oriyan Cohen, Prakash G. Jagtap, Sanaa Musa · 2025 · Tetrahedron
88. Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders
    Serena Deiana, Erica Zamberletti · 2017 · Elsevier eBooks
89. Plants with Phytomolecules Recognized by Receptors in the Central Nervous System
    H. Koltai, Z. Yaniv · 2021 · Springer eBooks
90. Cannabinoid treatment of opiate addiction
    Erin McLemon, Rose Chesworth · 2021
91. Case Study of Hair Regrowth with Topical Cannabidiol (CBD)
    Gregory Lawson Smith, John L. Satino · 2021 · International Society of Hair Restoration Surgery
92. Cannabinoid treatment of opiate addiction
    Erin McLemon, Rose Chesworth · 2021 · Neuroanatomy and Behaviour
93. Cannabidiol in medicinal usage of stress: Modeling investigations into cocaine
    Olga Valverde, María Julia García-Fuster · 2023 · Elsevier eBooks
94. Medical Use of Cannabinoids and Psychedelic Compounds
    Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi · 2023 · Springer eBooks
95. Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection
    Mohammad Hassan Kalantar Neyestanaki, Omid Gholizadeh, Fatemeh Hosseini, Sama Akbarzadeh, Saman Yasamineh, Hamed Afkhami, Somayeh Sedighi · 2024 · VirusDisease
96. In vivo Imaging of Cerebral Microglial Activation and Glutathione in Regular Cannabis Users
    Da Silva, Tania Sofia · 2018 · TSpace (University of Toronto)
97. Pharmacologic targeting of the CB2 cannabinoid receptor for application in centrally-mediated chronic pain
    Dana Marie Lambert · 2019 · cIRcle (University of British Columbia)
98. Cannabis-based medicinal products: a clinical guide
    Elisabeth Philips, Simon Erridge, Mikael Hans Sodergren · 2022 · British Journal of Neuroscience Nursing
99. Cannabidiol treatment of proliferating 3T3-L1 pre-adipocytes affects mature cell size and expression of acyltransferases involved in lipid droplet synthesis
    Cristina Caldari‐Torres, Mingyang Huang, Daniel A. Kasprovic, Yiyang Xu · 2023 · Research Square
100. Receptor-enriched analysis of functional connectivity (REACT) for understanding cannabinoid neuropsychopharmacology
     Ekaterina Shatalina, Natalie Ertl, Kat Petrilli, Shelan Ofori, Anna Borissova, Claire Mokrysz, H. Valerie Curran, Will Lawn, Tom P. Freeman, Oliver David Howes et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)